Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.01

-2.9%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scusami who wrote (9595)	10/20/1997 11:37:00 AM
From: Henry Niman	of 32384

Scusami, I have seen estimates of $1-$3 Billion for Rezulin sales for diabetes. I think that the total marketwill be larger because of prevention applications. CNBC has also talked about a $3 Billion market for LLY's new SERM, Evista for treating osteoporosis. In that area, LGND already has two in the clinic with PFE (Droloxifene,and CP-366,156) and more under development with AHP. Now they are throwing in cancer applications with LLY (and drugs that synergize for cancer will almost certainly synergize for osteoporosis - look at TZDs and Rexinoids for diabetes as weel as liposarcomas).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next